Spetzler David Baxley bought CAI

September 3, 2026 · Form 4 insider transaction

Spetzler David Baxley bought 1,000,000 shares of Caris Life Sciences, Inc. at $2.44 per share, a transaction worth $2.44M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.